These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37519257)

  • 1. COVID-19 and Anemia: What Do We Know So Far?
    Abu-Ismail L; Taha MJJ; Abuawwad MT; Al-Bustanji Y; Al-Shami K; Nashwan A; Yassin M
    Hemoglobin; 2023 May; 47(3):122-129. PubMed ID: 37519257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
    Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
    Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic anemia in COVID-19.
    Al-Kuraishy HM; Al-Gareeb AI; Kaushik A; Kujawska M; Batiha GE
    Ann Hematol; 2022 Sep; 101(9):1887-1895. PubMed ID: 35802164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment.
    Nilsson B; Persson B; Eriksson O; Fromell K; Hultström M; Frithiof R; Lipcsey M; Huber-Lang M; Ekdahl KN
    Front Immunol; 2022; 13():840137. PubMed ID: 35350780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulopathy in COVID-19 and anticoagulation clinical trials.
    Zhang H; Lao Q; Zhang J; Zhu J
    Best Pract Res Clin Haematol; 2022 Sep; 35(3):101377. PubMed ID: 36494146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.
    Montenegro F; Unigarro L; Paredes G; Moya T; Romero A; Torres L; López JC; González FEJ; Del Pozo G; López-Cortés A; Diaz AM; Vasconez E; Cevallos-Robalino D; Lister A; Ortiz-Prado E
    Expert Rev Respir Med; 2021 Feb; 15(2):183-195. PubMed ID: 32902367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Return-to-work, disabilities and occupational health in the age of COVID-19.
    Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
    Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
    Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases.
    Hamidi Z; Jabraeili-Siahroud S; Taati-Alamdari Y; Aghbash PS; Shamekh A; Baghi HB
    Virol J; 2023 Jan; 20(1):1. PubMed ID: 36611166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune Hemolytic Anemia After mRNA COVID Vaccine.
    Fatima Z; Reece BRA; Moore JS; Means RT
    J Investig Med High Impact Case Rep; 2022; 10():23247096211073258. PubMed ID: 35045762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases.
    Taherifard E; Taherifard E; Movahed H; Mousavi MR
    Hematology; 2021 Dec; 26(1):225-239. PubMed ID: 33594951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist.
    Zakeri A; Jadhav AP; Sullenger BA; Nimjee SM
    J Neurointerv Surg; 2021 Mar; 13(3):202-206. PubMed ID: 33298508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets and COVID-19.
    Rohlfing AK; Rath D; Geisler T; Gawaz M
    Hamostaseologie; 2021 Oct; 41(5):379-385. PubMed ID: 34695854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications.
    Haimei MA
    Clin Appl Thromb Hemost; 2020; 26():1076029620944497. PubMed ID: 32722927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.